Evaluation of macrocyclic hydroxyisophthalamide ligands as chelators for zirconium-89.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 28575044.
- Also identified by DOI 10.1371/journal.pone.0178767 and PMC identifier 5456358.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The development of bifunctional chelators (BFCs) for zirconium-89 immuno-PET applications is an area of active research. Herein we report the synthesis and evaluation of octadentate hydroxyisophthalamide ligands (1 and 2) as zirconium-89 chelators. While both radiometal complexes could be prepared quantitatively and with excellent specific activity, preparation of 89Zr-1 required elevated temperature and an increased reaction time. 89Zr-1 was more stable than 89Zr-2 when challenged in vitro by excess DTPA or serum proteins and in vivo during acute biodistribution studies. Differences in radiometal complex stability arise from structural changes between the two ligand systems, and suggest further ligand optimization is necessary to enhance 89Zr chelation.
Medical subject headings
- Amides
- Chelating Agents
- Macrocyclic Compounds
- Phthalic Acids
- Zirconium